← Open Payments lookup

RENE DARVEAUX: Open Payments

NPI 1205866696 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,216 in 62 payments from 20 companies in 2025. Trend: 2023 $1,723 · 2024 $1,460 · 2025 $1,216

Food & beverage: $1,216
CompanyPaymentsAmount
Novo Nordisk Inc13$267
GlaxoSmithKline, LLC.10$174
Lilly USA, LLC4$115
ABBVIE INC.5$100
Bayer Healthcare Pharmaceuticals Inc.4$73
AstraZeneca Pharmaceuticals LP3$59
Paratek Pharmaceuticals, Inc.2$54
Dexcom, Inc.2$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$48
Amgen Inc.3$48

Products named: TRELEGY ELLIPTA, JARDIANCE, Rybelsus, Wegovy, Ozempic, Kerendia, FARXIGA, XHANCE.

Industry payments across TX — which companies pay providers there.